Airborne exposure limits for chemical and biological warfare agents: Is everything set and clear?

International Journal of Environmental Health Research

Volumn 16, Issue 4, 2006, Pages 241-253

  Sabelnikov, Alex ^a   Zhukov, Vladimir ^a   Kempf, C ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

AELs; Airborne exposure limits; Chemical and biological warfare agents; Modeling of risks of infection

Indexed keywords

CHEMICAL WARFARE AGENT;

BIOLOGICAL WEAPON; CHEMICAL WEAPON;

AIRBORNE INFECTION; BIOLOGICAL WARFARE; ENVIRONMENTAL MONITORING; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MATHEMATICAL ANALYSIS; NONHUMAN; REVIEW; RISK FACTOR;

AIR POLLUTANTS; BIOLOGICAL WARFARE; BIOTERRORISM; CHEMICAL WARFARE; CHEMICAL WARFARE AGENTS; DECONTAMINATION; EMERGENCY MEDICAL SERVICES; ENVIRONMENTAL EXPOSURE; GUIDELINES; MODELS, BIOLOGICAL; PUBLIC HEALTH; RISK MANAGEMENT;

EID: 33745093507     PISSN: 09603123     EISSN: 13691619     Source Type: Journal    
DOI: 10.1080/09603120600734105     Document Type: Review

References (63)

1. Alibek K. 1999. Biohazard. New York: Random House.
2. Allan M, Richardson GM. 1998. Probability density functions describing 24-hour inhalation rates for use in human health risk assessments. Hum Ecol Risk Ass 4(2):379-408.
3. American Industrial Health Association. 2003. The 2003 Emergency Response Planning Guidelines and Workplace Environmental Exposure Level Guides Handbook. Fairfax, VA: AIHA Press.
4. American Conference of Governmental Industrial Health. 2003. Documentation of the Threshold Limit Values and Biological Exposure Indices. ACGIH Worldwide, Cincinnati, OH.
5. Borio L, Iglesby TV, Peters CJ, et al. 2002. Hemorrhagic fever viruses as biological weapon. Medical and public health management. JAMA 287(18):2391-2405.
6. Burlakova EB, Konradov AA, Maltseva EL. 2003. Effect of supersmall doses of biologically active substances and low-intensity physical factors. J Advances Chem Phys 2(2):140-162.
7. Centers for Disease Control (CDC). 1991. Epidemiologic notes and reports: Laboratory-acquired meningococcemia California and Massachusetts. MMWR 40(3):46-47, 55.
8. Centers for Disease Control (CDC). 1992. Seroconversion to simian immunodeficiency virus in two laboratory workers. MMWR 41(36):678-681.
9. Centers for Disease Control (CDC). 1998. Fatal cercopithecine herpes virus 1 (B virus) infection following a mucocutaneous exposure. MMWR 47(49):1073.
10. Centers for Disease Control (CDC). 2002. Airborne exposure limits for chemical warfare agents GA (tabun), GB (sarin), and VX. Federal Register Vol. 67(5):894-901.
11. Centers for Disease Control (CDC). 2003. Office of Health and Safety, BMBL, Introductory Section, www.cdc.gov/od/ohs/biosfty/bmbl4/bmbl4s1.htm
12. Chermashentsev VM, Zhukov VA, Maryasov AG, Safatov AS. 1993. Some theoretical approaches to evaluating the efficacy of antiviral drugs. Vestnik USSR Acad. Med Sci 9:3-7 [in Russian].
13. Coker PR, Smith K L, Fellows PF, Rybachuck G, Kousoulas KG, Hugh-Jones ME. 2003. Bacillus Anthracis virulence in guinea pigs vaccinated with anthrax vaccine absorbed is linked to plasmid quantities and clonality. J Clin Microbiol 41:1212-1218.
14. Department of Homeland Security/HSARPA. 2004. Department of Homeland Security, the Homeland Security Advanced Research Projects Agency (HSARPA). Available: http://www.hsarpabaa.com via the INTERNET.
15. Dahlgren CM, Buchanan LM, Decker HM, et al. 1960. Bacillus anthracis aerosols in goat hair processing mills. Am J Hyg 72:24-31.
16. Dennis DT, Iglesby TV, Henderson DA, et al. 2001. Tularemia as a biological weapon. Medical and public health management. JAMA 285(21):2763-2773.
17. European Good Manufacturing Practices (EU GMP). 1997. Guide to manufacture of sterile medicinal products.
18. Federal Standard 209E. 1992. Airborne particulate cleanliness classes in clean zones (metric), superseding FED-STD209D.
19. Fournier PE, Marrie TJ, Raolt D. 1998. Diagnosis of Q-fever. J Clin Microbiol 36(7):1823-1834.
20. Graham TW, Sabelnikov AG. 2004. How much is enough: Real-time detection and identification of biological weapon agents. J Homeland Sec Emerg Manage 1(3):Article 303.
21. Hauschild V. 2004. Summary of chemical agent air* exposure values. Available: www.osha.gov/SLTC/emergency preparedness/guides/ nerve_cwa_air_table_08032004.pdf via the INTERNET (Accessed March 2004 8).
22. Henderson DA, Iglesby TV, Bartlett JG, et al. 1999. Smallpox as a biological weapon medical and public health management. JAMA 281(22):2127-2137.
23. Hohoev TH, Kondrakova OA, Los SP, et al. 2002. About the possible mechanisms of action of ultra-low doses of some highly toxic compounds. Abstracts of International Symposium Mechanisms of action of ultra low doses. Moscow, Russia, December 3-6. p 38.
24. Hohoev TH, Babin VN, Kondrakova OA, et al. 2003. The enhancement of human body resistance towards the toxic effects of ultra low doses of highly toxic compounds. Abstracts of International Symposium Medical and biological aspects of demolition of chemical warfare agents. Volgograd. 26-28 August 2003. pp 181-184.
25. Honar H, Riazi AK, Homayoun AH, et al. 2004. Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on chronic seizures. Neuroscience 129:733-742.
26. Iglesby TV, Dennis DT, Henderson DA, et al. 2000. Plague as a biological weapon. Medical and public health management. JAMA 283(17):2281-2256.
27. Iglesby TV, O'Toole T, Henderson DA, et al. 2002. Anthrax as a biological weapon. Updated recommendations for management. JAMA 287(17):2236-2252.
28. International Organization for Standardization. ISO/DIS. 1998. Clean-rooms and associated controlled environments. Part 4: Design and construction.
29. Janeway CA, Travers P, Walport M, et al., editors. 2001. Immuno biology: The immune system in health and disease. New York, Oxford: Garland Publishing.
30. Johnson B. 2003. OSHA infectious dose white paper. Appl Biosafety 8(4):160-165.
31. Karalliedde L, Wheeler H, Maclehose R, Murray V. 2000. Possible immediate and long-term health effects following exposure to chemical warfare agents (review). Pub Health 114:238-248.
32. Lange T, Marshall L, Spath-Schwalbe E, et al. 2002. Systemic immune parameters and sleep after ultra low dose administration of IL-2 in healthy men. Brain, Behav, Immunity 16:663-674.
33. -20 M). Membr Cell Biol 12(2):251-268.
34. Marshall L, Weir E, Abelson A, Sanborn MD. 2002. Identifying and managing adverse environmental health effects: 1. Taking an exposure history. CMAJ 166(8):1049-1055.
35. Mayorov BI, Maryasov AG, Subkhinkhulov GF. 1989. Optimal aerosol technique of pesticides application (Rus.). Nauka, Novosibirsk (Rus).
36. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, Yampolskaya O. 1994. The Sverdlovsk Anthrax Outbreak of 1979. Science 266(18):1202-1208.
37. National Aeronautics and Space Administration (NASA). 1967. NASA standards for clean rooms and work stations for the microbially controlled environment. NHB 5340.2, Washington DC 20546.
38. Nikas M, Hubbard AE, Jones RM, Reingold AL. 2004. The infectious dose of Variola (smallpox) virus. Appl Biosafety 9(3):118-127.
39. National Research Council (NRC). 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: National Academy Press.
40. National Council on Radiation Protection and Measurements (NCRP). 2001. Report No. 138. Available: www.ncrponline.org/138press.html via the INTERNET.
41. Pasquarella C, Pitzurra O, Savino A. 2000. The index of microbial air contamination. J Hospital Infec 46:241-256.
42. Peto S. 1953. A dose-response equation for the invasion of micro-organisms. Biometrics 9(3):320-335.
43. Phillips GB. 1969. Control of microbiological hazards in the laboratory. Am Ind Hyg Assoc J 30(2):170-176.
44. Pier GB, Lyczak JB, Wetzler LM, editors. 2004. Immunology, infection, and immunity. Washington, DC: ASM Press.
45. Pike RM. 1976. Laboratory-associated infections: Summary and analysis of 3921 cases. Health Lab Sci 13(2):105-114.
46. Pike RM. 1978. Past and present hazards of working with infectious agents. Arch Pathol Lab Med 102:333-336.
47. Pike RM, Sulkin SE. 1952. Occupational hazards in microbiology. Scientif Month 222-227.
48. Pike RM. 1979. Laboratory-associated infections: Incidence. Fatalities, causes and prevention. Ann Rev Microbiol 33:41-66.
49. Powell KJ, Abul-husn NS, Jhamandas A, et al. 2002. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharm ExpTher 300:588-596.
50. Pukhalsky AL, Toptygina A, Khaidukov S. 1995. Interleukin-2 receptor β chain as a possible target for low doses of mafosfamide. Mediators Inflam 4:175-180.
51. Pukhalsky AL, Shmarina GV. 2001. Stimulatory and protective effects of alkylating agents applied in ultra-low concentrations. Pharmacology 62:129-132.
52. Raber E, Jin A, Noonan K, et al. 2001. Decontamination issues for chemical and biological warfare agents: how clean is clean enough? Int J Environ Health Res 11:128-148.
53. Raber E, Carlsen TM, Folks KJ, et al. 2004. How clean is clean enough? Recent developments in response to threats posed by chemical and biological warfare agents. Int J Environ Health Res 14(1):31-41.
54. Rocha ES, Santos MD, Chebabo SR, et al. 1999. Low concentrations of the organophosphate VX affect spontaneous and evoked transmitter release from hippocampal neurons: Toxicological relevance of cholinesterase-independent actions. Toxicol Appl Pharmacol 159:31-40.
55. Sanborn MD, Cole D, Abelsohn A, Weir E. 2002. Identifying and managing adverse environmental health effects: 4. Pesticides. CMAJ 166(11):1431-1436.
56. Sidell FR. 1996. Chemical agent terrorism. Ann Emerg Med 28:223-224.
57. Slepushkin AN. 1959. An epidemiologic study of laboratory infections with Venezuelan Equine Encephalomyelitis (VEE). Vopr Virusol 3:311-314 [in Russian].
58. Smith KA. 1993. Lowest dose interleukin-2 immunotherapy. Blood 6:1414-1423.
59. Sulkin SE, Pike RM. 1951. Survey of laboratory acquired infections. Am J Pub Health Nat Health 41:769-781.
60. US Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. Washington, DC: US Environmental Protection Agency. Report No EPA/600/6-90/066F.
61. National Council on Radiation Protection and Measurements (US NCRP). 2001. Management of Terrorist Events Involving Radioactive Material. Report No. 138.
62. Wedlum AG. 1964. Laboratory safety in research with infectious aerosols. Pub Health Rep 79(7):619-633.
63. Wehrle PF, Posch J, Richter KH, Henderson DA. 1970. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull WHO 43:669-679.